Evidence map›Paper›PMID 41758535›Full record

ArticleJournal of clinical hypertension (Greenwich, Conn.)2026

Association Between NHHR and Future Cardiovascular Disease Among Patients With CKM Stages 0-3: A Nationwide Prospective Cohort Study.

Yu Huang, Yanwen Gao, Jiming Shao, Ke Wang, Yexiang Ma, Long Ai, Jing Yu

Abstract read
In one paragraph

Article in Journal of clinical hypertension (Greenwich, Conn.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yu HuangDepartment of Cardiovascular Medicine, Lanzhou University Second Hospital, Lanzhou, China.
Yanwen GaoDepartment of Cardiovascular Medicine, Lanzhou University Second Hospital, Lanzhou, China.
Jiming ShaoDepartment of Cardiovascular Medicine, Lanzhou University Second Hospital, Lanzhou, China.
Ke WangDepartment of Cardiovascular Medicine, Lanzhou University Second Hospital, Lanzhou, China.
Yexiang MaDepartment of Cardiovascular Medicine, Lanzhou University Second Hospital, Lanzhou, China.
Long AiDepartment of Cardiovascular Medicine, Lanzhou University Second Hospital, Lanzhou, China.
Jing YuDepartment of Cardiovascular Medicine, Lanzhou University Second Hospital, Lanzhou, China.

Funding

Lanzhou University Second Hospital CY2021-MS-A13National Natural Science Foundation of China 81960086National Natural Science Foundation of China 82160089National Natural Science Foundation of China 82460086
6 · The paper itself

Abstract

The American Heart Association recently proposed the concept of Cardiovascular-kidney-metabolic (CKM) syndrome, emphasizing the interconnections among cardiovascular disease (CVD), chronic kidney disease (CKD), and metabolic disorders. The ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol (NHHR) has emerged as a novel lipid marker associated with CVD, but its relevance in individuals with CKM syndrome remains unclear. This study aimed to examine the association between NHHR and incident CVD among adults with CKM stages 0-3 using data from the China Health and Retirement Longitudinal Study (CHARLS). CVD events were defined as self-reported heart disease or stroke. Cox proportional hazards models and restricted cubic spline (RCS) analyses were applied to assess associations, and receiver operating characteristic (ROC) curves evaluated predictive performance. Among 7445 participants (mean follow-up: 80 months), 1476 developed CVD. Each one-unit increase in NHHR was associated with a 4% higher risk of CVD (95% CI: 1.00-1.08). Participants in the highest quartile (Q4) had a 23% higher risk compared with Q1 (HR = 1.23, 95% CI: 1.03-1.47). RCS analysis showed a significant positive linear relationship (P overall = 0.018). NHHR demonstrated the strongest predictive ability for CVD, with consistent results across subgroups. Higher NHHR levels were independently linked to increased CVD risk among individuals with CKM stages 0-3, suggesting NHHR may serve as a simple marker to identify high-risk populations.

Indexed as

Cardiovascular DiseasesCholesterol, HDLMetabolic SyndromeRenal Insufficiency, ChronicAgedBiomarkersChinaFemaleHumansIncidenceLongitudinal StudiesMaleMiddle AgedProspective StudiesRisk FactorsBiomarkersCholesterol, HDLcardio‐kidney‐metabolic syndromecardiovascular diseaseCHARLSNHHR

Identifiers

PMID41758535
PMCPMC12947834

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.